David R. Epstein - 17 Mar 2022 Form 4 Insider Report for Axcella Health Inc.

Role
Director
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Mar 2022
Net transactions value
$0
Form type
4
Filing time
21 Mar 2022, 16:30:20 UTC
Previous filing
18 Mar 2022
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXLA Common Stock Options Exercise +1,535 +0.95% 162,697 18 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 17 Mar 2022 Common Stock 50,000 $2.51 Direct F2
transaction AXLA Restricted Stock Units Options Exercise $0 -1,535 -100% $0.000000* 0 18 Mar 2022 Common Stock 1,535 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of AXLA common stock.
F2 The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) May 19, 2023 and (ii) the date of the 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service at such time.
F3 The RSUs are fully vested as of the date hereof.